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Abstract
A novel human coronavirus, SARS-CoV, emerged suddenly in 2003, causing approximately 8000 human cases and more
than 700 deaths worldwide. Since most animal models fail to faithfully recapitulate the clinical course of SARS-CoV in
humans, the virus and host factors that mediate disease pathogenesis remain unclear. Recently, our laboratory and others
developed a recombinant mouse-adapted SARS-CoV (rMA15) that was lethal in BALB/c mice. In contrast, intranasal infection
of young 10-week-old C57BL/6 mice with rMA15 results in a nonlethal infection characterized by high titer replication within
the lungs, lung inflammation, destruction of lung tissue, and loss of body weight, thus providing a useful model to identify
host mediators of protection. Here, we report that mice deficient in MyD88 (MyD88
2/2), an adapter protein that mediates
Toll-like receptor (TLR), IL-1R, and IL-18R signaling, are far more susceptible to rMA15 infection. The genetic absence of
MyD88 resulted in enhanced pulmonary pathology and greater than 90% mortality by day 6 post-infection. MyD88
2/2 mice
had significantly higher viral loads in lung tissue throughout the course of infection. Despite increased viral loads, the
expression of multiple proinflammatory cytokines and chemokines within lung tissue and recruitment of inflammatory
monocytes/macrophages to the lung was severely impaired in MyD88
2/2 mice compared to wild-type mice. Furthermore,
mice deficient in chemokine receptors that contribute to monocyte recruitment to the lung were more susceptible to
rMA15-induced disease and exhibited severe lung pathology similar to that seen in MyD88
2/2mice. These data suggest that
MyD88-mediated innate immune signaling and inflammatory cell recruitment to the lung are required for protection from
lethal rMA15 infection.
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Introduction
In2003,anovelcoronavirus,SARS-CoV,emergedfromzoonotic
pools of virus in China to cause a global outbreak of Severe and
Acute Respiratory Syndrome (SARS) affecting 29 countries, causing
over 8000 human cases and greater than 700 deaths [1–3]. The
clinical course of SARS-CoV disease in humans is characterized by
fever, non-productive cough, and malaise culminating in lung
infiltrates visible by X-ray and an atypical pneumonia [4–8].
Immunologically, SARS-CoV infection of humans generates a
cytokine/chemokine storm where elevated levels of IP-10, MIP1-a,
and MCP-1 are detected within the blood [9]. Histological
examination of lung tissue in terminal SARS-CoV cases revealed
SARS antigen primarily within bronchiolar epithelium, Type I and
II alveolar pneumocytes, and less frequently within macrophages
and lymphocytes in the lung, suggesting a roll for multiple cell types
in SARS-CoV pathogenesis [10,11].
Though clinical and epidemiological data from the epidemic
and reemergence has provided insight into the molecular
pathogenesis of SARS-CoV infection, thorough studies of virus
and host interactions have been hampered by the lack of animal
models that fully recapitulate human disease. C57BL/6 mice
infected with the epidemic strain, SARS Urbani, do not show any
overt signs of disease but there is virus replication in the lung
(10
7TCID50/g 3dpi), induction of a number of proinflammatory
chemokines, and viral clearance even in the absence of T, B, and
NK cells, suggesting that innate immunity alone is required for the
clearance of SARS Urbani within this acute model of SARS-CoV
replication [12]. The newly developed mouse adapted SARS-
CoV, MA15, differs from Urbani in 6 amino acids and infection of
young or senescent BALB/c mice with either MA15 or
recombinant MA15 (rMA15) results in high virus titers in the
lung, pulmonary pathology, and 100% mortality resembling the
pathogenesis of the most severe human cases of SARS-CoV
[5,10,13]. Unfortunately, a SARS-CoV mouse model does not yet
exist that recapitulates the less severe pathogenesis and recovery
seen in a majority of the human cases. Moreover, a model of
SARS-CoV pathogenesis with both disease and convalescence
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or adaptive protective response to infection.
Toll-like receptors (TLRs) are cellular receptors that recognize
molecular signatures of pathogens and initiate an inflammatory
signaling cascade that is critical to the innate immune response
[14]. Myeloid differentiation primary response gene 88 (MyD88) is
a key adaptor protein for most TLR-dependent inflammatory
signaling pathways as well as IL-1R1, IL-18R1 and IFNcR1
signaling pathways [14] MyD88 interacts with a variety of cellular
proteins leading to the activation of NF-kB, JNK, and p38 and the
induction of inflammatory cytokines, chemokines, and type I
interferons [14]. The role of MyD88 in the host response to viral
infection has been investigated for a number of viral pathogens.
These studies have indicated that MyD88 is crucial for the
response to some viral infections, while it appears dispensable for
others. For example, MyD88 signaling is not required for
clearance of reovirus infection after peroral inoculation of mice
[15]. In contrast, MyD88
2/2 mice infected with respiratory
syncytial virus (RSV), vesicular stomatitis virus (VSV), or
lymphocytic choriomeningitis virus (LCMV) results in more severe
disease [16–19]. Though TLR7/MyD88/IFNa dependent signal-
ing has been implicated as important in the pathogenesis of a
related coronavirus, mouse hepatitis virus (MHV), the role of
MyD88 signaling in SARS-CoV pathogenesis has not yet been
investigated [20].
In this study, we describe a novel C57BL/6 mouse model of
rMA15 acute pathogenesis characterized by high titer virus
replication within the lung, induction of inflammatory cytokines
and chemokines, and immune cell infiltration within the lung. WT
mice display signs of disease that include 12–15% loss of body
weight by 3 dpi and lung pathology, however, these mice recover
from infection by 6 dpi. Furthermore, we demonstrate a protective
role for MyD88-dependent regulation of innate and inflammatory
immune responses in this model of rMA15 pathogenesis.
MyD88
2/2 mice infected with rMA15 have significantly higher
and prolonged virus titers in the lung, exhibit a severe delay in host
immune and inflammatory responses, including monocyte/
macrophage recruitment to the lung, and ultimately succumb to
infection. In addition, mice deficient in chemokine receptors that
regulate the recruitment of inflammatory leukocytes to the lung
were also more susceptible to rMA15 infection. These data suggest
that a failure or delay in MyD88 inflammatory signaling and a
concurrent delay in inflammatory monocyte/macrophage recruit-
ment to the lung during acute infection results in exacerbated
SARS-CoV disease. This novel mouse model of acute SARS-CoV
pathogenesis could be extended to the investigation of many other
components of the innate immune response in order to form a
more comprehensive view of SARS-CoV pathogenesis, which may
guide the rational design of antiviral therapies.
Results
MyD88
2/2 mice are highly susceptible to rMA15
infection
Since previous studies suggested MyD88-dependent inflamma-
tory signaling was important for protection from severe disease
caused by VSV, LCMV, and RSV, we evaluated the importance
of MyD88 signaling in SARS-CoV pathogenesis [16,18,19,21]. To
assess the contribution of innate and adaptive immune responses
in SARS-CoV-induced disease, age matched C57BL/6 (WT)
(n=14), congenic RAG-1
2/2 (n=21), and congenic MyD88
2/2
(n=16) mice were infected intranasally with 10
5 pfu of
recombinant mouse-adapted SARS-CoV (rMA15) and monitored
for virus-induced morbidity and mortality. Infection of WT, RAG-
1
2/2, or MyD88
2/2 mice resulted in weight loss beginning at day
2 post-infection (Fig. 1A). Infected WT and RAG-1
2/2 mice lost
1464% and 964% of starting body weight by 3 dpi, respectively,
and returned to starting body weights by 5–6 dpi, indicating that
the mice had recovered from rMA15 induced disease. In contrast
to WT and RAG-1
2/2 mice, which began to recover weight after
3 dpi, infected MyD88
2/2 mice continued to lose weight after 3
dpi creating a significant weight disparity between WT and
MyD88
2/2 mice (WT vs. MyD88 percent weight p=,0.05 at 4,
5, and 6 dpi). While 100% of WT and 86% of RAG-1
2/2 mice
survived the infection, .90% of MyD88
2/2 mice (n=16)
succumbed to infection by 6 dpi (Fig. 1B). MyD88 plays a critical
role in proinflammatory signaling following stimulation of all
known TLR’s, except TLR3, as well as IL1R and IL18R.
Interestingly, 100% of IL-1R1- or IL-18R1-deficient mice
survived infection by rMA15 (data not shown) indicating that
the genetic absence of either receptor did not recapitulate the
lethal phenotype observed following infection of MyD88
2/2 mice.
These findings indicate that i) adaptive immunity does not play a
major role in protection from lethal SARS-CoV infection in mice,
ii) the genetic absence of MyD88 significantly enhances SARS-
CoV-induced morbidity and mortality , and iii) MyD88-depen-
dent signaling through a receptor(s) other than IL-1R1 or IL-18R1
is responsible for protection from rMA15.
Increased viral loads and viral spread in the lungs of
MyD88
2/2 mice
To determine if lethal infection of MyD88-deficient mice was
due to enhanced and/or prolonged virus replication, a kinetic
analysis of rMA15 viral loads within the lungs of WT, RAG-1
2/2,
and MyD88
2/2 mice was performed. Viral loads in lung tissue of
rMA15-infected MyD88
2/2 mice were significantly higher than
WT mice at 2, 3, 4, and 6 dpi and RAG-1
2/2 mice at both 2 and
4 dpi (Fig. 1C). Interestingly, despite the absence of significant
signs of disease at late time points, viral lung titers remained
elevated in lung tissue of rMA15-infected RAG-1
2/2 mice at 7
Author Summary
In 2002, a new human coronavirus (CoV), termed SARS-
CoV, emerged in southern China from coronaviruses
circulating within live animals sold for food. Due to the
ease and speed of human global travel, this new
respiratory virus rapidly spread worldwide, illustrating the
need to better understand how these viruses cause
disease and how the immune system responds to
infection. SARS-CoV infection of the human lower respira-
tory tract caused an atypical pneumonia characterized by
viral replication in lung tissue and lung inflammation
visible by chest X-ray. To identify how the immune system
responds to and provides protection from SARS-CoV
infection, we have developed a mouse model that mimics
many aspects of SARS-CoV disease in humans. Utilizing this
mouse model, we discovered that a host gene, termed
MyD88, is required to control SARS-CoV replication and
spread in lung tissue and for protection from death. In
addition, MyD88-dependent functions were required for
early immune and inflammatory responses in the lung
following SARS-CoV infection, and the absence of these
early responses correlated with severe SARS-CoV-induced
disease and death. Our studies identify host immune
responses that provide protection from SARS-CoV infec-
tion and provide valuable insight toward the development
of successful antiviral therapies.
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were observed in rMA15-infected RAG-1
2/2 mice as late as
5 weeks post-infection (data not shown). In addition to lung tissue,
viral titers were also determined for the brain, liver, kidney, and
spleen. Infectious virus was not detected in the brain, liver, or
kidney of WT or MyD88
2/2 mice at 1, 3, or 4 dpi (limit of
detection=250 pfu/gram of tissue; n=4–5 mice per time point).
Sporadic viral titers were detected in the spleens of WT and
MyD88
2/2 mice (data not shown). These findings indicate that
the greater mortality observed in rMA15-infected MyD88
2/2
mice was not due to enhanced replication at extrapulmonary sites.
To further assess the role of MyD88 in controlling SARS-CoV
replication within the lung, in situ hybridization was performed on
Figure 1. MyD88
2/2 mice are highly susceptible to rMA15
infection and experience higher levels of virus replication
within the lung as compared to WT mice. 10 week-old C57BL/6 WT
(n=14), RAG-1
2/2 (n=21), or MyD88
2/2 (n=16) mice were infected
intranasally with 10
5 pfu rMA15. (A) Mice were monitored for changes in
body weight at 24 h intervals. Each data point represents the mean 6
the standard deviation. Asterisks indicate statistical significance by the
non-parametric Mann-Whitney test with a P,0.05. (B) Mice were
monitored for mortality. Data is expressed as a percent survival value.
(C) WT, MyD88
2/2 or RAG-1
2/2 mice were infected intranasally with 10
5
pfu rMA15. Lung tissues from 3–6 mice per strain were harvested on 1,
3, 4, 6, and 9 dpi. Lung tissues were homogenized in DPBS and virus
titers within clarified supernatants were assessed by plaque assay. Mean
titers are displayed and error bars represent 1 standard deviation. *,
P,0.05 as determined by the Mann-Whitney test.
doi:10.1371/journal.ppat.1000240.g001
Figure 2. Virus replication is sustained and distribution is more
widespread within the lungs of MyD88
2/2 mice as compared to
WT mice. 5 mM paraffin-embedded sections derived from the lung
tissue of WT and MyD88
2/2 mice were hybridized with an
35S-UTP-
labeled riboprobe complementary to either the N gene of SARS-CoV
(Urbani) or to the EBER2 gene from Epstein-Barr virus (data not shown).
Images (magnification, 1006) are representative of at least three mice.
doi:10.1371/journal.ppat.1000240.g002
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35S-labeled riboprobe complementary for
the N gene of SARS-CoV. As shown in Fig. 2, in situ signal was
not observed in lung sections derived from mice that received
intranasal administration of PBS alone (top panels). At both 1 and
2 dpi, intense rMA15-specific in situ signal was observed
throughout the lung tissue, including lung airway epithelia, in
rMA15-infected WT and MyD88
2/2 mice. However, by 3 to 4
dpi, the distribution and intensity of rMA15-specific in situ signal
had greatly diminished in lung tissue of WT mice, while the
rMA15-specific signal in MyD88
2/2 mice was more intense and
much more broadly distributed (Fig. 2). By 6 dpi, though
diminished, rMA15-specific in situ signal was still readily
detectable in lung tissue of MyD88
2/2 mice, whereas only very
rare rMA15-specific in situ signal could be detected in lung tissue
of WT mice. In sum, these findings suggest that MyD88 is
required for control of MA15 replication in pulmonary tissue at
early times post-infection and that the inability to control or clear
this early replication is associated with increased lethality.
Decreased expression of proinflammatory cytokines and
chemokines in MyD88
2/2 mice
Infection of WT mice with rMA15 results in a rapid
inflammatory response in the lungs. This virus-induced inflam-
matory response likely has both protective and pathologic
consequences. To investigate the importance of MyD88 in
SARS-CoV-induced lung inflammation, we employed quantitative
RT-PCR (qRT-PCR) to assess mRNA levels of antiviral and
proinflammatory cytokine/chemokine gene expression in the
infected mouse lung at various times post-infection. MyD88 is
required for the induction of type I IFN in mouse cells following
stimulation of TLR7 and TLR9 [14]. However, similar to
previous reports, we were unable to detect significant induction
of type I IFN in lung tissue of either WT or MyD88
2/2 mice
following SARS-CoV infection by qRT-PCR (Fig. 3A) or in serum
using a type I IFN bioassay (data not shown) compared to mock-
infected control mice [22]. Type III IFNs, which are induced by
viral infection and TLR ligands, also have direct antiviral affects
[23]. Recently, lung tissue and epithelial cells were found to be
responsive to type III interferon in vivo, suggesting that type III
IFN may function to prevent viral infection at mucosal surfaces
[24,25]. Interestingly, SARS-CoV infection of either WT or
MyD88
2/2 mice resulted in similar induction of type III IFN over
mock-infected mice which peaked at 2 dpi and declined thereafter
(Fig 3A). In fact, induction of type III IFN was slightly higher,
although not statistically significant, in infected MyD88
2/2 mice
at all time points analyzed. Taken together, these findings suggest
that the enhanced susceptibility of MyD88
2/2 mice is not due to a
failure to induce a protective type I IFN response, which was
undetectable in both strains of mice, or type III IFN response,
which was similar in both strains of mice.
Infection of WT mice with rMA15 resulted in a significant
induction of proinflammatory chemokines including CCL2 (MCP-
1), CCL3 (MIP-1a), and CCL5 (RANTES) as compared to mock-
infected control mice (Fig. 3B). In contrast to type I and type III
IFNs, induction of CCL2 was dramatically reduced in rMA15-
infected MyD88
2/2 mice compared to WT mice at 2 dpi (14 fold
difference, P,0.005). Statistically significant differences in the
abundance of CCL2 mRNA were not detected at 4 or 6 dpi
(Fig. 3B). Similarly, the induction of CCL3 (22 fold difference at 2
dpi, P,0.005; 5 fold difference at 4 dpi, p,0.005) and CCL5 (8 fold
differenceat 2 dpi,P,0.005; 8 fold difference at 4 dpi, P,0.01) were
dramatically reduced in infected MyD88-/- compared to infected
WT mice (Fig. 3B). In addition to proinflammatory chemokines,
virus-induced expression of several proinflammatory cytokines,
including TNF-a (9 fold difference at 2 dpi, P,0.005; 3 fold
difference at 4 dpi, p,0.005), IL-1b (3.8 fold difference at 2 dpi,
P,0.01), and IL-6 (11 fold difference at 2 dpi, P,0.005); , was
severely impaired in rMA15-infected MyD88
2/2 mice compared to
infected WT mice (Fig. 3C). These data indicate that MyD88 is
required for the early induction of proinflammatory chemokines and
cytokines within pulmonary tissues of SARS-CoV-infected mice and
suggest that some aspect(s) of this inflammatory response is required
for protection from lethal disease.
Extensive lung pathology and delayed inflammation
MyD88
2/2 mice
The levels of inflammatory chemokine and cytokine transcription
suggested that the innate immune response was severely delayed in
MyD88-deficient mice as compared to WT mice. To assess lung
damageand pulmonaryinflammationthroughoutthecourseofvirus
infection in WT and MyD88
2/2 mice, we evaluated hematoxylin
andeosinstainedlungtissuesectionsfrom2,4and 6dpi(Fig.4).At2
dpi, MyD88
2/2 mice exhibited a denuding bronchiolitis character-
ized by an extrusion of airway epithelial cells into the lumen of the
airway and epithelial/endothelial atypia (vacuolization and disrup-
tion of normal epithelium and endothelium) but did not exhibit any
obvious signs of inflammatory cell infiltration including peribronch-
ivascular (PBV) or peri-venular immune cell infiltration (‘‘cuffing’’).
In contrast, WT mice at 2 dpi exhibited pronounced lung
inflammation characterized by perivascular cuffing, endothelial
and epithelial atypia, and peribronchivascular immune cell infiltra-
tion, without the severe denuding bronchiolitis seen in MyD88
2/2
mice (Fig. 4). At 4 dpi, MyD88
2/2 mice continued to exhibit a
denuding bronchiolitis, epithelial/endothelial atypia, and the added
phenotype of PBV edema without immune cell infiltration around
the airway though perivascular infiltration of immune cells was
observed (Fig. 4). Similar to what was seen at early times post
infection, WT mice at 4 dpi had an exacerbation of the
inflammatory infiltrate seen at 2 dpi, but denuding bronchiolitis
and PBV edema were not observed. Interestingly, by 6 dpi, the
severity of PBV edema and denuding bronchiolitis in MyD88
2/2
mice had waned, and signs of lung inflammation were evident, with
marked PBV infiltrates and perivascular cuffing even more severe
than that seen in WT mice at similar times post infection. These
findings suggestthat MyD88 is essential for the early induction of the
host inflammatory response and the timely recruitment of
inflammatory leukocytes in the SARS-infected lung.
Delayed recruitment of inflammatory monocytes to
lungs of MyD88
2/2 mice
The expression analyses of proinflammatory chemokines/cyto-
kines and the lung pathology suggested that MyD88 is critical for
early immune/inflammatory responses in lung tissue following
SARS-CoV infection. To investigate whether the impaired chemo-
kine and cytokine responses in MyD88
2/2 mice impacted the
cellular composition within the lung, total leukocytes were isolated
from enzymatically digested pulmonary tissue and the cell surface
phenotypes of the isolated cells were determined by flow cytometry.
At 2 dpi, no significant differences were detected in the number
of natural killer cells (NK1.1
+/CD3
2) or T lymphocytes (CD4
+/
CD3
+/NK1.1
2 or CD8
+/CD3
+/NK1.1
2) isolated from the lung
tissue of mock-infected or SARS-CoV infected WT mice (data not
shown). These findings suggested that the differences in inflam-
mation in rMA15-infected WT and MyD88
2/2 mice observed in
the histological analyses of lung tissue were likely due to differences
in myeloid cell populations. Therefore, anti-CD11b, anti-CD11c,
anti-Gr-1, and anti-F4/80 antibodies were used to define the
MyD88 Protects from Lethal Infection with SARS-CoV
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macrophages (CD11c
+/F4/80
+/CD11b
low/2), dendritic cells
(CD11c
+/CD11b
2 or CD11b
+/F4/80
2/Gr-1
2), inflammatory
monocytes/macrophages (CD11b
+/F4/80
+/Gr-1
int/CD11c
2),
and neutrophils (Gr-1
high/CD11b
+/F4/80
2/CD11c
2) [26–28].
As shown in Fig. 5A, cell surface staining of lung leukocytes with
anti-Gr-1, anti-F4/80, and anti-CD11b antibodies revealed two
distinct cell populations, defined by region 3 (R3) and R4/R5 in
the histograms, that were significantly increased in both
percentages (Fig. 5B) and total numbers (Fig. 5C) in rMA15-
infected WT mice as compared to mock-infected mice. The cells
defined by R3 in our analyses have a Gr-1
high/F4/80
2/CD11b
+
cell surface phenotype (Fig. 5A and data not shown), which is
consistent with that of neutrophils, and were modestly increased in
the lung tissue of rMA15-infected WT mice at 2 dpi (Fig. 5B and
5C). The most dramatic differences detected in percentages and
total numbers were cells with a Gr-1
int/F4/80
+/CD11b
+ cell
surface phenotype defined in R4 and R5 (Fig 5A, B, and C).
Additional analyses demonstrated that these cells were Ly6C
+ and
CD11c
2 (data not shown). This cell surface staining pattern,
including the Gr-1
int and F4/80
low staining, has been well
characterized by a number of studies as that of inflammatory
monocytes [26–35]. Strikingly, both the Gr-1
high/F4/80
2 popu-
lation (R3) and the Gr-1
int/F4/80
+/CD11b
+ inflammatory
monocyte/macrophage population (R4 and R5) were dramatically
reduced in lung tissue of rMA15-infected MyD88
2/2 mice
Figure 3. rMA15 induction of proinflammatory genes is reduced in MyD88
2/2 mice. WT (black bars) and MyD88
2/2 mice (white bars) were
inoculated intranasally with PBS (grey bars) or 10
5 pfu rMA15. At 2, 4, and 6 dpi, mice were euthanized and total lung RNA was analyzed for mRNA
expression by qRT-PCR. Levels of gene transcription for Type I and Type III interferons (A), proinflammatory chemokines (B) and proinflammatory
cytokines (C) were assessed. Data are normalized to 18S rRNA and are expressed as the relative fold increase over PBS inoculated mice. The data
presented are the means from 3–4 mice per timepoint 6 the standard error of the means. *, P,0.05.
doi:10.1371/journal.ppat.1000240.g003
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dpi, similar numbers of inflammatory monocytes were detected in
infected MyD88
2/2 and mock-infected control mice (Fig. 5C). To
determine if the failure to recruit inflammatory monocytes/
macrophages was sustained at later times post infection in
MyD88
2/2 mice, we performed similar cell isolation experiments
at 4 dpi. In contrast to 2 dpi and consistent with our histological
analysis of lung tissue, at 4 dpi, a similar percentage and total
number of Gr-1
int/F4/80
+/CD11b
+/CD11c
2 inflammatory
monocytes/macrophages were isolated from the lung tissue of
WT and MyD88
2/2 mice (Fig. 5D). Similar to 2 dpi, we did not
detect significant numbers of CD3
+ T lymphocytes within the lung
tissue of rMA15-infected mice compared to PBS-inoculated
control mice on 4 dpi, indicating that T lymphocytes were not a
major component of the inflammatory response at these times
post-infection (data not shown). These results further indicate that
MyD88 is critical for early host immune and inflammatory
responses, which include the initial recruitment of inflammatory
monocytes/macrophages to pulmonary sites, in response to
rMA15 infection.
Chemokine receptors contribute to protection from
mouse-adapted SARS-CoV infection
The histological and flow cytometric analyses outlined above
suggested that monocytes/macrophages are i) the major cell
population increased in the SARS-infected lung at early times
post-infection, ii) increased in the lung by a MyD88-dependent
mechanism, and iii) critical for protection against severe rMA15-
induced disease. In addition, in response to rMA15 infection,
MyD88
2/2 mice failed to upregulate expression of a number of
proinflammatory chemokines that promote monocyte recruitment.
Therefore, we hypothesized that mice deficient in monocytes or
specific chemokine receptors important for recruitment of
inflammatory monocytes may be more susceptible to rMA15-
induced disease. We attempted to deplete circulating monocytes
by IP injection of clodronate liposomes or alveolar monocytes/
macrophages by IN administration of clodronate liposomes in
C57BL/6 mice prior to rMA15 infection. Though we were able to
deplete alveolar macrophages by IN administration of clodronate
liposomes, both IP and IN administration of clodronate liposomes
failed to alter morbidity and mortality and failed to prevent the
Figure 4. Lung pathology in rMA15 infected WT and MyD88
2/2 mice. To assess lung damage and pulmonary inflammation throughout the
course of virus infection, we evaluated hematoxylin and eosin stained lung tissue sections from 2, 4 and 6 dpi. WT mice at 2 dpi exhibited
pronounced lung inflammation characterized by perivascular cuffing (filled arrowhead), endothelial and epithelial atypia (vacuolization and
disruption of normal epithelium and endothelium), with minor denuding bronchiolitis (empty arrowhead) as seen in MyD88
2/2 mice. Similar to what
was seen at early times post infection, WT mice on 4 dpi show an exacerbation of the inflammatory infiltrate (filled arrowhead) seen on 2 dpi, PBV
edema was not observed. By 6 dpi, normal bronchiolar epithelial architecture is restored but inflammatory infiltrates are still present. At 2 dpi,
MyD88-/- mice exhibited a denuding bronchiolitis characterized by an extrusion of airway epithelial cells into the lumen of the airway (empty
arrowhead) and epithelial/endothelial atypia, but did not exhibit any obvious signs of inflammation like peribronchivascular (PBV) or peri-venular
immune cell infiltration. On 4 dpi, MyD88
2/2 mice continue to exhibit a denuding bronchiolitis (empty arrowhead), epithelial/endothelial atypia, and
now show PBV edema without a pronounced immune cell infiltration around the airway though perivascular cuffing was observed (filled arrowhead).
Interestingly, by 6 dpi, the severity of PBV edema and denuding bronchiolitis in MyD88
2/2 mice had waned, and signs of immune cell infiltration
were evident, with marked PBV infiltrates and perivascular cuffing (filled arrowhead) even more severe than that seen in WT mice at similar times post
infection. Overall, the host immune response to the virus was similar in quality and quantity, but delayed in onset by 5–6 days in the MyD88
2/2 mice.
Vascular and bronchiolar lumen are labeled as VL and BL, respectively.
doi:10.1371/journal.ppat.1000240.g004
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dpi (data not shown). Additionally, the intranasal administration of
clodronate liposomes 2 days post rMA15 infection of C57BL/6
mice failed to induce more severe disease or mortality. Due to
inconclusive results from our clodronate depletion studies and to
continue to explore the importance of monocyte recruitment in
SARS-CoV disease, we infected mice deficient in chemokine
receptors known to be important for monocyte recruitment. As
shown in Fig. 6A, mice deficient in CCR1, CCR2, or CCR5
developed more severe and prolonged disease as compared to WT
mice. Between 3 and 14 dpi, CCR1 and CCR2 percent weight
differed significantly from WT mice, while CCR5 weight differed
significantly from WT between 2 and 13 dpi (Fig. 6A). Unlike
CCR2 and CCR5 deficient mice, 40% of infected CCR1 deficient
mice succumbed to infection by 7 dpi (Fig. 6B). To assess the lung
damage and degree of pulmonary inflammation in chemokine
receptor deficient mice, we evaluated hematoxylin and eosin
stained lung sections from 2 dpi (Fig. 6C). Signs of inflammation
and virus induced lung pathology are evident in wild-type mice on
2dpi with PBV cuffing caused by infiltrating immune cells,
apoptosis of the airway epithelium, and a mild denuding
bronchiolitis. In contrast, mice deficient in either CCR1, CCR2
or CCR5 exhibited more prominent airway epithelial cell
apoptosis, a severe denuding bronchiolitis with an accumulation
of cohesive apoptotic debris within the airway, and perivenular/
periarterial cuffing but there was a distinct lack of cuffing around
the affected airways. In direct correlation with the increased
morbidity and mortality of rMA15 infected CCR1 deficient mice,
the lung pathological conditions described above were the most
severe in CCR1 deficient mice.
Discussion
Since human clinical SARS data is complicated by host genetic
variation, disease exacerbating comorbidities, age variation, and
variable drug treatment regimens, animal models provide a more
homogenous and controlled environment within which to ask
questions related to the mechanisms of disease pathogenesis. Prior
to the generation of a mouse adapted SARS-CoV (MA15) which
causes 100% mortality in BALB/c mice, previous SARS-CoV
BALB/c or C57BL/6 animal models using the epidemic strain,
SARS Urbani, were purely models of in vivo virus replication
without overt signs of disease [12,13,36,37]. In contrast to previous
models, our novel C57BL/6 model of SARS-CoV pathogenesis
recapitulates disease similar to non-severe human SARS-CoV
cases with high virus titer replication in the lung, significant weight
loss, elevated inflammatory cytokine/chemokines, the recruitment
of inflammatory cells to the lung, viral clearance and subsequent
convalescence [4–6,9]. Furthermore, the recovery from rMA15
disease is dependent on MyD88 but does not seem to be
dependent on the presence of functional T or B cells (Fig. 1A).
In contrast to a previous report where RAG-1
2/2 mice were
demonstrated to clear SARS Urbani (dose: 1610
4 TCID50) with
similar kinetics as compared to WT mice, we demonstrate that
RAG-1
2/2 mice recover from disease signs with similar kinetics as
WT mice but are unable to clear (dose: 10
5 pfu) the more robust
rMA15 [12]. The discrepancy regarding clearance of virus in
RAG-1
2/2 mice may be due to the differing doses used and/or
the enhanced pathogenesis of the mouse adapted virus. The
disease observed in our rMA15 C57BL/6 disease model has also
been observed with a second independently derived mouse
adapted SARS-CoV suggesting that the disease phenotype is not
simply an artifact of the rMA15 mutational spectra but that both
sets of mouse adapting mutations enhance the intrinsic pathogenic
potential of the epidemic strain (data not shown). Taken together,
the morbidity and mortality data for rMA15 infected WT, RAG-
1
2/2, and MyD88
2/2 mice suggest that early MyD88 dependent
innate signals are required for protection from rMA15 induced
mortality.
Serological and pathological data from the SARS-CoV
epidemic suggests that the innate immune response plays a crucial
role in the control of SARS-CoV infection but the molecular
mechanisms of innate immune activation, protection from severe
disease, and the contribution of the innate response to immune
pathology remain unknown [5,9,10,38]. MyD88 is a key signaling
adaptor protein for most all TLRs, IL-1R1, IL-18R1, and IFNc-
R1 [14]. Contrary to previous virological studies [16–19,21,39],
we have demonstrated MyD88 plays a crucial role in protection
from SARS-CoV infection independent of Type I (a/b) and III
(IL-28/29 or interferon lambda) interferon, and the adaptive
immune response. Though MyD88 mediated proinflammatory
signaling has been implicated in the protection from numerous
bacteria and parasitic infections, few in vivo studies have
implicated MyD88 in protection from viral diseases [16–
19,21,40–44]. Intranasal infection of MyD88-deficient mice with
RSV or VSV produces more severe disease that was correlated
with a failure to recruit immune cells to the sites of infection
[17,18]. For RSV, MyD88-dependent induction of type I
interferon correlated with the recruitment of eosinophils to the
lung and efficient virus clearance [17]. In contrast, MyD88-
dependent protection from lethal VSV infection occurred
independent of type I interferon, correlated with the recruitment
of monocytes to the site of infection and was dependent on IL-1R1
signaling [18]. In the C57BL/6 mouse model of SARS-CoV
pathogenesis reported here, we demonstrate MyD88-mediated
protection from SARS-CoV infection in the absence of detectable
induction of type I interferon. Furthermore, infection of IFNa/b
receptor deficient mice with rMA15 results in moderate weight
loss and complete recovery with kinetics that is indistinguishable
from those of WT mice (personal communication, Frieman and
Baric, manuscript in preparation). Unlike RSV and VSV, we
found that WT C57BL/6 mice are protected from lethal SARS-
CoV infection by a MyD88-dependent mechanism that does not
involve adaptive immunity, the induction of type I/III interferon,
or IL1-R/IL-18R signaling (data not shown) suggesting that
SARS-CoV is interfacing with the innate immune system in a
potentially novel manner.
Human cases of SARS-CoV, mouse models, and in vitro data
suggest inflammatory chemokines and cytokines and the recruit-
Figure 5. Recruitment of inflammatory monocytes/macrophages to the SARS-CoV infected lung is delayed in MyD88
2/2 mice as
compared to WT mice. 10 wk old B6 WT or MyD88
2/2 mice were inoculated intranasally with PBS or 10
5 pfu rMA15. (A) At 2 dpi, lung leukocytes
were isolated as described in Materials and Methods and analyzed by flow cytometry. Histograms are representative of three mice. Two independent
experiments gave similar results. (B) Percent inflammatory monocytes/macrophages of total lung leukocytes isolated from mock (%), rMA15-infected
WT (&), or rMA15-infected MyD88
2/2 (&) mice at 2 dpi. (C) Total numbers of inflammatory monocytes/macrophages isolated from mock (%),
rMA15-infected WT (&), or rMA15-infected MyD88
2/2 (&) mice at 2 dpi. (D) Percent inflammatory monocytes/macrophages of total lung leukocytes
(left panel) and total numbers of inflammatory monocytes/macrophages (right panel) isolated from mock (%), rMA15-infected WT (&), or rMA15-
infected MyD88-/-n (&) mice at 4 dpi.
doi:10.1371/journal.ppat.1000240.g005
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chemokine receptors in SARS-CoV pathogenesis we infected CCR1, CCR2, and CCR5 deficient mice with a recombinant mouse adapted SARS-CoV
(rMA15). (A) Mice were monitored for changes in body weight at 24 h intervals. Each data point represents the mean 6 the standard deviation. On
days 3–14 dpi (*), the differences in the weights of CCR1 and CCR2 mice as compared to WT mice were statistically different by Mann-Whitney test
with a P value cutoff of 0.05. On days 3–13 dpi (**), the differences in the weights of CCR5 deficient and WT mice were statistically different by Mann-
Whitney test with a P value cutoff of 0.05 (B) Mice were monitored for mortality and the data is expressed as percent survival. (C) To assess the lung
damage and degree of pulmonary inflammation in chemokine receptor deficient mice, we evaluated hematoxylin and eosin stained lung sections
from 2 dpi. Signs of inflammation and virus induced lung pathology are evident in wild-type mice on 2 dpi with peribronchivascular cuffing (filled
arrowhead) caused by infiltrating immune cells, apoptosis of the airway epithelium, and a mild denuding bronchiolitis (empty arrowhead). In
contrast, mice deficient in either CCR1, CCR2, or CCR5 exhibited more prominent airway epithelial cell apoptosis, a severe denuding bronchiolitis with
an accumulation of cohesive apoptotic debris within the airway (empty arrowhead) , and perivenular/periarterial cuffing (filled arrowhead) but there
was a distinct lack of cuffing around the affected airways. Bronchiolar and vascular lumen is labeled as ‘‘BL’’ and ‘‘VL’’, respectively.
doi:10.1371/journal.ppat.1000240.g006
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pathogenesis [5,10]. Our studies indicate that protection from
SARS-CoV infection correlates with MyD88-dependent induction
of IL1-b, TNF-a, IL-6, MCP-1, MIP-1a, and RANTES at early
times post infection and many of these cytokines/chemokines were
upregulated in human SARS-CoV cases [9,45]. At early times post
rMA15 infection, the MyD88-dependent chemokine/cytokine
response occurs with the recruitment of inflammatory mono-
cytes/macrophages to the lung at 2 dpi and is coincident with the
control of virus replication in WT animals. Days 2, 3, 4 and 6 post
infection, virus titers are significantly lower in WT mice as
compared to MyD88
2/2 animals and these data are supported by
the dramatic loss of in situ hybridization signal in WT mice by 3
dpi. Furthermore, the lung pathology and flow cytometry results
suggest that the absence of inflammation in MyD88
2/2 mice at
early times post infection (2 dpi) correlates with much more severe
lung damage and by the time the host mounts an adequate
inflammatory response (4 dpi), lung damage is too severe and
mortality ensues. The importance of macrophages in SARS-CoV
pathogenesis has been noted in the past where SARS antigen was
frequently detected in macrophages in the pathological evaluation
of post mortem lung tissues from human SARS-CoV cases [11].
Interestingly, in vitro data suggests that macrophages are not
productively infected by SARS-CoV, however, these cells secrete
inflammatory cytokines like IP-10 and MCP-1 in response to the
virus [46]. We have yet to determine the cell type responsible for
the induction of the MyD88-dependent protective inflammatory
response though we have demonstrated the recruitment of
inflammatory monocytes/macrophages occurs even if alveolar
macrophages are depleted in WT mice (data not shown). In the
future, bone marrow chimeras between WT and MyD88
2/2 mice
may help deduce if myeloid derived cells are responsible for the
initial induction of the protective inflammatory response.
Chemokine receptors play a crucial role in directing inflamma-
tory leukocytes to the sites of infection in order to mount an
effective immune response [28,47]. CCR1, CCR2 and CCR5
each bind a unique repertoire of chemokine ligands but all are able
to guide the trafficking of monocytes and other leukocytes to sites
of inflammation [28,47]. Previous reports have implicated that
that chemokine receptors, CCR1, CCR2 and CCR5 can both
promote protection (CCR1,CCR2) and progression (CCR5) of
disease caused by a neurovirulent coronavirus and the chemokine
receptor dependent alteration of disease correlated with the
recruitment of inflammatory leukocytes to the sites of infection
[48–50]. Our studies demonstrate the importance of chemokine
receptors in protection from rMA15 disease where CCR1, CCR2
and CCR5 deficient mice experienced a significantly more severe
disease and associated mortality as compared to WT mice.
Furthermore, infected CCR deficient mice suffered from severe
lung pathology (denuding bronchiolitis, epithelial apoptosis, etc.)
and defects in inflammatory cell recruitment to the airway that
were very similar to those seen in MyD88
2/2 mice. CCR1 (MCP-
1), CCR2 (MIP-1a) and CCR5 (MIP-1a and RANTES) bind
chemokines upregulated in the lungs of rMA15 infected WT mice
whose expression are coincident with the recruitment of
inflammatory leukocytes to the lung and protection from
mortality. Recent data from Glass et al. suggest that CCR5
dependent recruitment of monocytes, T cells and NK cells to the
brains of West Nile virus infected WT mice are required for the
control of virus replication in the CNS and protection from
mortality [51]. CCRs can also guide immunopathogenesis during
virus infection where CCR2 deficient mice are protected from a
lethal influenza virus infection due to the failure to recruit
inflammatory monocytes to the infected lung [27]. Taken
together, the above data suggests an important role for MyD88-
dependent inflammation, the innate immune response, and
chemokine recruitment of inflammatory cells in both the
prevention and progression of severe SARS-CoV disease.
Viral pathogenesis is a complex process where interactions
between the virus and the host determine the outcome of virus-
induced disease. Many of the pathogenic mechanisms of SARS-
CoV disease remain unknown and the existence of a robust mouse
model of SARS-CoV pathogenesis will allow for the detailed
analysis of virus-host interactions. We have developed a novel
model of acute SARS-CoV pathogenesis. Using this model, we
discovered a critical role for MyD88-dependent inflammation in
the protection from SARS-CoV induced mortality suggesting that
the innate immune response plays a key role in the early control of
SARS-CoV in the lung. Our future studies are aimed at
understanding the mode of MyD88 dependent innate immune
activation and the molecular mechanisms of inflammatory
monocyte clearance of SARS-CoV from the lung. In the future,
our studies may guide epidemiological studies in human
populations in order to deduce if MyD88 related inflammatory
genes or CCRs contributed to protection or prevention of severe
SARS-CoV disease. Importantly, our SARS-CoV disease model
can be employed to study the contributions of various innate
immune genes in the protection from severe SARS-CoV disease
which eventually may help clarify the current view of SARS-CoV
pathogenesis and guide the development of intelligently designed
antiviral therapies.
Materials and Methods
Viruses and Cells
Vero E6 cells were grown in MEM (Invitrogen, Carlsbad, CA)
supplemented with 10% FCII (Hyclone, South Logan, UT) and
gentamycin/kanamycin (UNC Tissue Culture Facility). Stocks of
the recombinant mouse-adapted SARS-CoV (rMA15) were
propagated and titered on Vero E6 cells and cryopreserved at
280uC until use as described [52]. All viral and animal
experiments were performed in a Class II biological safety cabinet
in a certified biosafety level 3 laboratory containing redundant
exhaust fans while wearing personnel protective equipment
including Tyvek suits, hoods, and HEPA-filtered powered air-
purifying respirators (PAPRs) as described [52].
Mice
C57BL/6J (stock# 000664) , RAG-1
2/2 (stock# 002216), IL-
1R1
2/2 (stock# 003245), and IL-18R
2/2 (stock# 004131) mice
were obtained from The Jackson Laboratory (Bar Harbor, Maine)
a n db r e di nh o u s e .M y D 8 8
2/2 mice were obtained from Shizou
Akira (Osaka University) and backcrossed 11 generations to the
C57BL/6 background. CCR1
2/2,C C R 2
2/2,C C R 5
2/2,a n d
controlC57BL/6wereobtainedfromTaconicLaboratories.Animal
housing and care were in accordance with all UNC-Chapel Hill
Institutional Animal Care and Use Committee guidelines. 10 week
old mice were anaesthetized with a mixture of ketamine/xylazine
and intranasally infected with either DPBS alone or 10
5pfu/50 ml
rMA15 or the recombinant epidemic strain, icSARS, in DPBS
(Invitrogen, Carlsbad, CA). Mice were monitored at 24 h intervals
for virus-induced morbidity and mortality.
Viral tissue and serum titers
To quantify the amount of infectious virus in tissues, lung, liver,
kidney, spleen, and brain tissue were weighed, placed in 0.5 ml
DPBS, homogenized, and titered via plaque assay on Vero E6 cells
as previously described [53]. Whole blood was harvested via
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separation. Serum was titered via plaque assay as described above.
Histological Analysis
Lung tissues were fixed in PBS/4% paraformaldehyde, pH 7.3,
tissues were embedded in paraffin, and 5 mm sections were
prepared by the UNC histopathology core facility. To determine
the extent of inflammation, sections were stained with hematoxylin
and eosin (H & E) and scored in a blinded manner.
In situ hybridization
35S-UTP-labeled riboprobes specific to the N gene of SARS-CoV
(Urbani) or to the EBER2 gene from Epstein-Barr virus (negative
control probe) were generated with an SP6-specific MAXIscript in
vitro transcription kit (Ambion) and in situ hybridization was
performed as described previously [37]. Briefly, deparaffinized tissue
sections were hybridized with 5610
4 cpm/mlo f
35S-labeled
riboprobes overnight. Tissues were washed, dehydrated through
graded ethanol, coated in NTB autoradiography emulsion (Kodak),
and incubated at 280uC for 7 days. Following development,
sections were counterstained with hematoxylin and silver grain
deposition was analyzed by light microscopy. rMA15-specific signal
was determined by comparing silver grain deposition on parallel
sections hybridized with the
35S-labeled riboprobe complementary
for the EBER2 gene of Epstein-Barr virus.
qRT-PCR
Lungs from mock- or rMA15-infected mice were removed and
homogenized directly in 1 ml of Trizol reagent (Invitrogen) and
total RNA was isolated following the manufacturer’s instructions.
Complementary DNA was generated from 0.25–1 ug of total
RNA using 250 ng random primers (Invitrogen) and superscript
III reverse transcriptase (Invitrogen). Real-time PCR experiments
were performed using Taqman gene expression assays and an
AB Prism 7300 (Applied Biosystems). 18S rRNA was used as an
endogenous control to normalize for input amounts of cDNA. The
relative fold induction of amplified mRNA were determined by
using the Ct method.
Flow cytometry
Mice were inoculated as described above, sacrificed by
exsanguination at 2 and 4 days post-infection, and lungs were
perfused via cardiac puncture with 16PBS. Lungs were dissected,
minced, and incubated for 2 hours with vigorous shaking at 37uC
in digestion buffer [RPMI, 10% FBS, 15 mM HEPES, 2.5 mg/ml
collagenase A (Roche), 1.7 mg/ml DNase I (Sigma)]. Cells were
passed through a 40 micron cell strainer, resuspended in RPMI
media, layered on 5 ml lympholyte-M (Cedarlane), and centri-
fuged 30 minutes at 2500 rpm. Banded cells were collected,
washed in wash buffer (16 HBSS, 15 mM HEPES), and total
viable cells were determined by trypan blue exclusion. Isolated
cells were incubated with anti-mouse FccRII/III (2.4G2; BD
Pharmingen) for 20 min. on ice and then stained in FACS staining
buffer (16 HBSS, 1% FBS, 2% normal rabbit serum) with the
following antibodies from eBioscience: anti-F4/80-FITC, anti-Gr-
1-PE, anti-CD11b-APC, anti-CD11c-PE, anti-Ly-6C-FITC, anti-
CD3-FITC, anti-CD8-APC, anti-CD4-PerCP, and anti-NK1.1-
PE. Cells were fixed overnight in 2% paraformaldehyde and
analyzed on a Cyan cytometer (Dako) using Summit software.
Statistical analyses
Percent starting weights, viral titers and inflammatory cell
numbers were evaluated for statistically significant differences by
the non-parametric Mann-Whitney test within GraphPad Prism or
unpaired t-tests using GraphPad InStat3 software. P values of
#0.05 were considered significant.
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